SCHEMBL1483167

SCHEMBL1483167

N#Cc1ccc(NC(=O)C(F)Cl)cn1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KCNQ3 O43525 3/20 0.53
KCNQ2 O43526 3/20 0.53
AR P10275 2/20 0.50
SCN10A Q9Y5Y9 1/20 0.40
CHEK1 O14757 5/20 0.40
KCNE1 P15382 2/20 0.39
KCNQ1 P51787 2/20 0.39
BRAF P15056 1/20 0.38
IDO1 P14902 1/20 0.38
SLC6A3 Q01959 1/20 0.36
KCNH2 Q12809 1/20 0.36
TAAR1 Q96RJ0 1/20 0.36
BACE1 P56817 1/20 0.35
PDPK1 O15530 1/20 0.35
DYRK3 O43781 1/20 0.35
MAP4K4 O95819 1/20 0.35
RET P07949 1/20 0.35
PIM1 P11309 1/20 0.35
KDR P35968 1/20 0.35
CSNK1D P48730 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1483214 0.88 KCNQ3 (0.52) KCNQ3KCNQ2ARSCN10ACHEK1
SCHEMBL1483919 0.85 AR (0.53) KCNQ3KCNQ2ARSCN10ACHEK1
SCHEMBL1483215 0.81 ALDH1A1 (0.48) KCNQ3KCNQ2ARCHEK1
SCHEMBL19776339 0.80 KCNQ3 (0.56) KCNQ3KCNQ2ARSCN10ACHEK1
SCHEMBL3305812 0.78 AR (0.57) KCNQ3KCNQ2ARSCN10ACHEK1
SCHEMBL3949406 0.78 AR (0.52) KCNQ3KCNQ2ARSCN10ACHEK1
SCHEMBL1483890 0.77 AR (0.60) KCNQ3KCNQ2ARSCN10ACHEK1
SCHEMBL13036452 0.76 AR (0.59) KCNQ3KCNQ2ARCHEK1BRAF
SCHEMBL20942380 0.76 AR (0.59) KCNQ3KCNQ2ARSCN10ACHEK1
SCHEMBL31680457 0.76 AR (0.59) KCNQ3KCNQ2ARCHEK1BRAF

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8314103-B2 Pyridyl derivatives, their preparation and use Piramal Enterprises Limited (IN) 2012-11-20 US disclosed
US-20110077252-A1 PYRIDYL DERIVATIVES, THEIR PREPARATION AND USE Piramal Enterprises Limited (IN) 2011-03-31 US disclosed
WO-2009019656-A1 PYRIDYL DERIVATIVES, THEIR PREPARATION AND USE PIRAMAL LIFE SCIENCES LIMITED (IN) 2009-02-12 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110077252-A1 PYRIDYL DERIVATIVES, THEIR PREPARATION AND USE HIF1AN, HIF1A, MTOR KCNQ3 4563/4885KCNQ2 4546/4885AR 3332/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.